Vyne Therapeutics
Price & Volume
Stats
See more52W Range | $0.28-$4.30 |
Market Cap | $8.4M |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $476,000 |
Revenue Growth (YoY) | -65.2% |
Gross Profit (12 Mos) | $476,000 |
Diluted EPS | -$0.90 |
News
See moreYahoo Finance • last month
Vitiligo Clinical Trial Pipeline Accelerates as 18+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight
Yahoo Finance • 2 months ago
The trading volume of these stocks is deviating from the norm in today's session.
Yahoo Finance • 2 months ago
Sector Update: Health Care Stocks Decline in Late Afternoon Trading
Yahoo Finance • 2 months ago
VYNE's vitiligo treatment fails primary endpoint in phase 2b trial
About
CEO | Mr. David T. Domzalski |
CFO | Mr. Tyler Zeronda CPA |
Address | 685 Route 202/206 N, Bridgewater, NJ, United States, 08807 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 13 |
